The Chinese medicine formula HB01 reduces choroidal neovascularization by regulating the expression of vascular endothelial growth factor

BACKGROUND: Choroidal neovascularization (CNV) remains the leading cause of newly acquired blindness in the developed world. Currently anti-vascular endothelial growth factor (VEGF) therapies are broadly used to treat neovascular ocular disorders. Here we demonstrate the effect of a traditional Chin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Ming, Zhang, Youhua, Pan, Lin, Dou, Renhui, Nussenblatt, Robert B, Wei, Lai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479009/
https://www.ncbi.nlm.nih.gov/pubmed/22676316
http://dx.doi.org/10.1186/1479-5876-10-118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479009/
https://www.ncbi.nlm.nih.gov/pubmed/22676316
http://dx.doi.org/10.1186/1479-5876-10-118

Ejemplares similares